Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NKF-INS(L) vs US and EU Humalog in Healthy Volunteers
NCT07165652Phase 1Completed
- Sponsor
- Xentria
- Start
- Oct 2025
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of insulin lispro in diabetes mellitus (DM) (3 arms), sponsored by Xentria. Primary endpoints: Pharmacokinetic Similarity and Pharmacodynamic Similarity. Started Oct 2025; status: completed.
02
Drugs
insulin lispro
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT07165652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07165652.